25 May 2013
Keywords: archimedes, announces, positive, ph, results, t3, heart
Article | 16 June 2008
UK drug development firm Archimedes and USA-based T3 therapeutics have released positive Phase I study data of their oral formulation ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 June 2008
24 May 2013
© 2013 thepharmaletter.com